The FXR induces MRP2 expression to facilitate BA excretion and protect against cholestasis, while Nrf2 activation upregulates MRPs such as MRP1, MRP2, and MRP3, enhancing cellular detoxification and protecting against oxidative and chemical stress [43]. The gene discussed is ABCC3; the disease is cholestasis.